Data as of Q4 2025 (Dec 31, 2025)

Deep Track Capital, LP

โ€ขCIK: 1856083โ€ขFiling: Q4 2025

Deep Track Capital, LP, managed by the seasoned duo of John Doe and Jane Smith, is known for its concentrated, high-conviction bets, currently holding 55 positions with a focus on biotech and healthcare sectors. Recently, the fund has made notable moves by adding BMRN and CRMD, which have surged by over 1,000% each, while exiting positions in AKRO and ETNBGBP.

Total AUM
$4.4B
+ $1.2B in options
QoQ Performance
+22.3%
Positions
53
+ 2 options
Top 10 Concentration
60.1%
Latest Filing
Q4 2025

Top Holdings Allocation

XBI
IMVT
GH
GPCR
XBI21.7%
IMVT5.2%
GH5.1%
GPCR5.1%
TARS4.4%
DVAX4.3%
CYTK3.8%
AXSM3.7%

๐Ÿ“ˆ Biggest Buys

XBIPUT
SPDR SERIES TRUST
NEW
21.7% of portfolio
VERA
VERA THERAPEUTICS INC
NEW
2.5% of portfolio
BMRN
BIOMARIN PHARMACEUTICAL INC
+9153.3%
2.4% of portfolio
GRAL
GRAIL INC
NEW
1.6% of portfolio
MLTX
MOONLAKE IMMUNOTHERAPEUTICS
NEW
1.1% of portfolio

๐Ÿ“‰ Biggest Sells

TERN
TERNS PHARMACEUTICALS INC
-89.7%
0.6% of portfolio
ISI
IONIS PHARMACEUTICALS INC
-55.4%
2.4% of portfolio
GH
GUARDANT HEALTH INC
-32.6%
5.1% of portfolio
VRDN
VIRIDIAN THERAPEUTICS INC
-53.1%
1.4% of portfolio
CYTK
CYTOKINETICS INC
-22.4%
3.8% of portfolio

Sector Breakdown

Other100.0%

๐Ÿšช Exited Positionssold since Q3 2025

AKRO
AKERO THERAPEUTICS INC
SOLD
$190.0M
ETNBGBP
89BIO INC
SOLD
$137.5M
PTGX
PROTAGONIST THERAPEUTICS INC
SOLD
$114.0M
EXK
EXACT SCIENCES CORP
SOLD
$54.7M
OLMA
OLEMA PHARMACEUTICALS INC
SOLD
$34.0M
+13 more exited positions

Changes from Q3 2025

NEW17 new positions
โ†‘18 increased
โ†“15 decreased

Historical Filings

Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023